ARTICLE | Company News
Hospital del Mar, University of Turin, Biocartis deal
May 2, 2016 7:00 AM UTC
Hospital del Mar, via its Hospital del Mar Medical Research Institute (IMIM) tech transfer office, and the university granted Biocartis exclusive rights to EGFR resistance mutations in colorectal can...